Comments on: Addressing endocrine disrupting chemicals requires an integrated strategy EU news and policy debates across languages Wed, 14 Nov 2018 17:29:28 +0000 hourly 1 By: Anthony C. Tweedale Fri, 21 Jul 2017 07:20:41 +0000 Right on! But no mention of an additional barrier: the Commission also specified, in the same regulation, the test methods to be used in determining if a chemical causes any adverse endocrine effect. This annex does specify the ED determination is to be made on “all available and relevant data”.

But industry’s toxicity test methods are preferred, both explicitly (not having to be systematically reviewed) and implicitly (in some of the six listed characteristics). Since laws, rules and custom both globally and in the EU already say, for other endpoints, that industry’s tests are reliable enough to determine safe exposure levels; nothing will change.

That is to say: 8,000 (and accelerating) published low dose toxicity findings will continue to be ignored for all endpoints in hazard or risk assessment of chemicals including pesticides.

Only when NGOs, scientists and enough regulators pay attention to this, will industry’s control over keeping their toxic chemicals in use cease. Endocrine hazard is just one part of this problem.